Rating Rationale
February 07, 2020 | Mumbai
Meghmani Organics Limited
Ratings upgraded to 'CRISIL AA-/Stable/CRISIL A1+'
 
Rating Action
Total Bank Loan Facilities Rated Rs.629 Crore
Long Term Rating CRISIL AA-/Stable (Upgraded from 'CRISIL A+/Positive')
Short Term Rating CRISIL A1+ (Upgraded from 'CRISIL A1')
1 crore = 10 million
Refer to annexure for Details of Instruments & Bank Facilities
Detailed Rationale

CRISIL has upgraded its ratings on the bank facilities of Meghmani Organics Limited (MOL; part of the Meghmani Group) to 'CRISIL AA-/Stable/CRISIL A1+' from 'CRISIL A+/Positive/CRISIL A1'.
 
The upgrade follows the continued strong operating performance of the group marked by healthy contributions from agrochem, pigments and base chemicals segments.
 
The agrochem division in particular grew by a strong 30% in the first nine months of the current fiscal driven largely by the pickup in export demand. Both agrochem and pigments sustained healthy double-digit margins in the current fiscal owing to healthy operating efficiencies and favorable product mix. For the base chemicals division that is under MFL, revenues and margins have declined as expected earlier largely due to the drop in electro chemical unit (ECU) realizations, however cash generation remains healthy. The recently commissioned chloromethane sulphonate (CMS) capacity has scaled up to ~70% utilization by December 2019. Going forward, with the hydrogen peroxide and new caustic soda capacities expected to commission in March 2020 (albeit a delay of 2-3 months against previous estimates), accruals are expected to further improve next fiscal.
 
CRISIL also notes the announcement by MOL on January 29, 2020 wherein the company's board had approved the demerger of the businesses of standalone MOL (i.e) agrochem and pigments into a separate subsidiary, Meghmani Organochem Limited (MOCL); followed by amalgamation  of other Business of MOL ( Trading and Equity investment in MFL)  with its 57% subsidiary, Meghmani Finechem Limited (MFL; rated 'CRISIL A+/Rating Watch with Developing Implications (RWDI)') and subsequent listing of both MOCL and MFL as two separate entities. Eventually MOCL will be renamed as Meghmani Organics Limited.  
 
CRISIL currently consolidates the business and financial risk profiles of both MOL and its subsidiary to arrive at the ratings of MOL. CRISIL notes that the proposed demerger of the MOL and MFL will result in limited financial fungibility between the two entities. However, CRISIL notes that the critical operational synergies, common branding and common promoters between the two entities will remain post demerger also.
 
In event of a demerger, the credit risk profile of MOL on a standalone basis will continue to remain healthy supported by the relatively stable business risk profile of the pigments and agrochemicals divisions. The standalone financial risk profile of MOL is expected to remain strong over the medium term with debt/EBITDA sustaining at less than 1.5 times and interest cover of over 20 times. 
 
Group's capital expenditure (capex) is expected to be around Rs 1100 crore over fiscals 2020 to 2022 towards expansion of chlor-alkali, hydrogen peroxide and ECH units along with expansions in agrochemical business. CRISIL expects the group's consolidated revenue to sustain a healthy compound annual growth rate (CAGR) of 13-15% over the medium term with scaling up of new capacities. Improving product mix, growing synergies and continued strong backward integration in each business segment will support the group to maintain healthy operating margins at over 20% during this period leading to healthy cash accruals.
 
While this sizeable capex is partly debt-funded, financial risk profile will remain healthy marked by gearing of less than 0.9 times expected as on March 31, 2020. Capital structure should improve further over the medium term as benefits of capex accrue to the business. While the group has made progress on the large expansion plans, successful commercialization of remaining projects and ramp up of the new capacities will remain a key monitorable over the near to medium term.
 
The ratings continue to reflect the Meghmani group's established market position in the pigments and agrochemicals segments, and diversified revenue in terms of products and end-user industries. The ratings also factor in the significant cost advantage derived from integrated operations, and comfortable financial risk profile. These strengths are partially offset by large working capital requirement, exposure to risks inherent in the agrochemicals sector and cyclicality in the caustic soda segment. Besides group also remains exposed to risks arising from project implementation, stabilisation and ramp-up in sales during the initial stages.

Analytical Approach

For arriving at the ratings, CRISIL has combined the business and financial risk profiles of MOL and all its subsidiaries, together referred to as the Meghmani group, as all the entities are under a common management and have operational linkages and fungible cash flow.

Please refer Annexure - List of entities consolidated, which captures the list of entities considered and their analytical treatment of consolidation.

Key Rating Drivers & Detailed Description
Strengths
* Established market position in the pigments and agrochemical industries
The Meghmani group has an established market position in its principal business segments: pigments and agrochemicals. It is the largest producer of copper phthalocyanine (CPC) blue and is among the top 3 pigment blue players globally, and enjoys long-standing relationship with key customers. In agrochemicals also, the group is among the largest manufacturer of pesticides in India having presence across the value chain in both technical and formulations. The group has more than 30 brands of various pesticides formulations in India.
 
* Diversified revenue profile
The group has diversified revenue streams with an estimated 38% of its revenue came from agrochemicals, 29% from pigments, and 34% from basic chemicals in fiscal 2019. Revenue diversity is further augmented by presence in both domestic (47%) and international markets (53%). Besides, new products in base chemicals, agrochemicals and pigments will add to further diversity in revenue streams.
 
* Integrated operations, leading to cost advantages
The Meghmani group has integrated backwards into manufacturing CPC blue, resulting in considerable savings. In its agrochemicals business, the group has facilities for manufacturing cypermethric acid chloride, meta phenoxy benzaldehyde and meta phenoxy benzyl alcohol, which are key intermediates in crop-protection products, thus reducing reliance on import. In the base chemicals segment too, the group has announced projects for manufacturing value-added products such as hydrogen peroxide, methylene dichloride, ECH, chloroform and carbon tetra chloride from hydrogen and chlorine, which are by-products of existing manufacturing processes. CRISIL believes healthy integration of production facilities will stand the Meghmani group in good stead over the medium term, and profitability will remain healthy above 20%.
 
* Comfortable financial risk profile
The Meghmani group's financial risk profile is supported by adequate networth and gearing.
 
The group has planned a capex of around Rs 1100 Cr between fiscals 2020 and 2022, largely towards expansion of caustic soda capacity and new facility for chloromethane, hydrogen peroxide and ECH in MFL, besides setting up capacity for new products in the agrochemical division. Despite this part debt funded capex, the group's credit metrics are expected to remain adequate on the back of healthy margins, improving cash generation, and scheduled repayment of term debt. Gearing and net cash accruals to total debt estimated at 0.4 times as on March 31, 2020 and interest cover at 6 times for fiscal 2020.
 
Weaknesses
* Large working capital requirement
The Meghmani group has large working capital requirement as its key businesses are seasonal. A large proportion of agrochemical sales in the domestic market and pigment sales in the overseas market are made in the second and fourth quarters, respectively, of the fiscal. Although export partially offsets dependence on the seasonal domestic agrochemicals market, it exerts pressure on working capital management as the group has to provide credit of 3-4 months to overseas clients, resulting in large receivables. However lower working capital requirements in Chlor Alkali & its Derivatives business partly offsets high GCA in agrochemical and pigments division. Nevertheless, CRISIL believes the Meghmani group's working capital requirement will remain large because of the nature of its business.
 
* Susceptibility to cyclicality in the chlor alkali segment
The chlor alkali industry is intensely competitive and dominated by large players. The top seven players account for close to 50% of the market share. Furthermore, the industry is susceptible to governmental regulations and cyclicality. The profitability of the caustic soda manufacturing companies depends on the prevailing ECU prices. Caustic soda and chlorine prices are volatile. Cyclical downturns or adverse changes in the demand-supply balance may result in lower realisations for caustic soda manufacturers.
 
* Exposure to risks inherent in the agrochemicals sector
The demand for agrochemicals is driven by agricultural production, which depends on monsoon. A substantial area under cultivation in India is still not well irrigated, and depends on the monsoon to meet water requirement. Surplus or inadequate rainfall could affect the Meghmani group's domestic revenue and profitability. Furthermore, the agrochemicals industry is regulated by specific and separate registration processes in different countries. Changes in the export and import policy of these countries will affect Indian agrochemical exporters such as the Meghmani group. Ban on any key molecules will also be a monitorable.
 
* Exposure to risks related to project implementation and stabilisation
The group has four ongoing projects ' Capacity addition for CMS, Caustic Soda, Hydrogen peroxide (all three of which in subsidiary, MFL) and Agrochemicals; of which, one is in the early stage of implementation (Agrochemicals), two have made moderate progress (Caustic Soda and Hydrogen Peroxide) and one is recently commissioned (CMS). The company has also recently announced a new project (ECH) which is yet to be initiated and will come on stream over the medium term. This in turn exposes the group to project-related risks over the medium term such as the risk of time or cost overrun, stabilisation and ramp up in operations post completion. Significant delays in project implementation and stabilization can impact ability to generate cash flows and will remain a key rating sensitivity factor.
Liquidity Strong

The group's liquidity is strong. It is supported by improving cash generation, expected at Rs 250-300 crore annually, which will suffice to service long term debt obligations of Rs 64 crore in fiscal 2020 and Rs 160-180 crore per annum in fiscals 2021 and 2022 and incremental working capital requirements. The group has also tied up long term loans for funding the incremental capex in the Chlor Alkali & its Derivatives business over fiscals 2020 to 2022. The group also has headroom in its fund based working capital limits which have been utilised at an average of 45% over the past nine months ended January 2020.

Outlook: Stable

CRISIL believes that Meghmani group's business performance will remain healthy over the medium term marked by improving product mix, diversified revenue profile and healthy margins leading to strong cash accruals. Besides, financial risk profile is also expected to remain healthy driven by comfortable capital structure and healthy accretion to reserves, despite large on-going capex plans. MOL's credit profile will also remain stable post demerger due to healthy cash flows, and strong balance sheet on standalone basis as well.

Rating Sensitivity Factors
Upward Factors
*Sustenance of healthy performance marked by at least 10-12% revenue growth and operating margins sustaining at over 18-20%
*Further strengthening of credit metrics through prudent capex spends and working capital management 'debt/EBITDA of less than 1.5 times.

Downward Factors
*Significant moderation in operating performance - revenues declining by over 8-10% and operating margins deteriorating to less than 10-12% on a sustained basis
*Significant delay in commissioning and ramp up of new capacities or higher than expected debt availed for funding the capex leading to deterioration in credit metrics - debt/EBITDA deteriorating to over 3 times.

About the Group

The Meghmani group was established in 1986, promoted by Mr Jayanti Patel, Mr Ashish Soparkar, Mr Natwarlal Patel, Mr Ramesh Patel, and Mr Anand Patel. The group manufactures green and blue pigment products, which are used to manufacture printing ink, plastic, paints, textiles, leather, and rubber. It also manufactures a wide variety of commonly used pesticides for crop and non-crop applications. The latter includes insect control in wood preservation and food grain storage. In July 2009, the group commissioned its caustic soda plant, which has capacity of 187,600 tonne per annum and is powered by a 60-megawatt captive power plant. MOL is listed on the Singapore Stock Exchange, National Stock Exchange of India Ltd, and BSE Limited.
 
In fiscal 2019, MOL gave an exit to the external investor ' International Finance Corporation (IFC) by buying back IFC's 25% stake in MFL for Rs 221.7 Cr. As part of this transaction, MOL infused funds in its fully owned subsidiary - Meghmani Agrochemicals Private Limited (MAPL) which in turn was used to buy IFC's stake. Subsequently, MOL merged MAPL with MFL. As part of the merger transaction, MFL redeemed the non-convertible compulsorily redeemable preference shares (NCRPS) of MAPL amounting to Rs 221.7 Cr using its internal cash accruals. MFL also issued optionally convertible redeemable preference shares (OCRPS) of Rs 210.9 Cr to MOL. These OCRPS are likely to be redeemed over the next 5-7 years post stabilization of MFL's cashflows.  
 
CRISIL also notes the announcement by MOL on January 29, 2020 concerning board approval for demerger of the Agrochem and Pigments businesses (along with the optionally convertible redeemable preference shares (OCRPS) issued to MFL) into a fully owned subsidiary Meghmani Organochem Limited (MOCL). Other Business of MOL (Trading and equity investment in MFL) will be amalgamated with its 57% subsidiary, MFL and the existing shareholders of MOL will be issued equity shares in both MOCL and MFL. Eventually MOCL will be renamed as Meghmani Organics Limited (MOL). Through this, the company aims to unlock shareholder value by demerging MOL (housing agrochem and pigments businesses) and MFL (housing the Chlor Alkali & its Derivatives business) into two separate listed entities. The company is now awaiting approval from the concerned authorities for the demerger.

For the first nine months of fiscal 2020, on a consolidated basis, MOL had revenues of about Rs 1671 crore and PAT of Rs 232 crore as compared to revenues of Rs 1530 crore and PAT of Rs 218 crore in the corresponding period of the previous fiscal.

Key Financial Indicators (Consolidated)
Particulars Unit 2019 2018
Revenue Rs Cr 2,088 1,803
Profit After Tax (PAT) Rs Cr 295 238
PAT Margin % 14.1 13.2
Adjusted Debt/Adjusted Networth Times 0.6 0.37
Interest Coverage Times 9.7 11.15

Any other information: Not applicable

Note on complexity levels of the rated instrument:
CRISIL complexity levels are assigned to various types of financial instruments. The CRISIL complexity levels are available on www.crisil.com/complexity-levels. Users are advised to refer to the CRISIL complexity levels for instruments that they consider for investment. Users may also call the Customer Service Helpdesk with queries on specific instruments.
Annexure - Details of Instrument(s)
ISIN Name of Instrument Date of Allotment Coupon Rate (%) Maturity Date Issue Size (Rs.Cr) Rating Assigned with Outlook
NA Cash Credit@ NA NA NA 150.0 CRISIL AA-/Stable
NA Cash Credit$ NA NA NA 60.0 CRISIL AA-/Stable
NA Cash Credit^ NA NA NA 80.0 CRISIL AA-/Stable
NA Export Packing Credit* NA NA NA 35.0 CRISIL AA-/Stable
NA Letter of Credit and Bank Guarantee NA NA NA 35.0 CRISIL A1+
NA Letter of Credit and Bank Guarantee! NA NA NA 40.0 CRISIL A1+
NA Rupee Term Loan NA NA Sep-2024 129.0 CRISIL AA-/Stable
NA Proposed Long Term Bank Loan Facility NA NA NA 100.0 CRISIL AA-/Stable
@Interchangeable between WCDL/EPC/PCFC/PSFC. Interchangeable between Overdraft/ Short Term Loan/Export & Local Bills Discounted/Export Invoice Financing
$Interchangeable between Working Capital demand loan (WCDL)/Export Packing Credit (EPC)/ Preshipment Credit in Foreign Currency (PCFC)
^Interchangeable between CC/WCDL/EPC/Foreign Usance Bills Discounting (FUBD)/Foreign Bills Purchased (FBP)/PCFC/Post Shipment Credit in Foreign Currency (PSCFC)/Inland Bills Purchased/ Discounted
*Interchangeable between Overdraft/ Short Term Loan/Export & Local Bills Discounted/Export Invoice Financing
!Interchangeable with buyer's credit
 
Annexure - List of Entities Consolidated
Name of entity Extent of consolidation Rationale for consolidation
Meghmani Finechem Limited Full Subsidiary, common management and operational linkages
Meghmani Europe BVBA Full Subsidiary, common management and operational linkages
Meghmani Organics USA Inc Full Subsidiary, common management and operational linkages
PT Meghmani Organics Indonesia Full Subsidiary, common management and operational linkages
Meghmani Overseas FZE Full Subsidiary, common management and operational linkages
Annexure - Rating History for last 3 Years
  Current 2020 (History) 2019  2018  2017  Start of 2017
Instrument Type Outstanding Amount Rating Date Rating Date Rating Date Rating Date Rating Rating
Commercial Paper  ST    --    --    --  17-04-18  Withdrawal  15-05-17  CRISIL A1  -- 
Fund-based Bank Facilities  LT/ST  554.00  CRISIL AA-/Stable      30-09-19  CRISIL A+/Positive  21-09-18  CRISIL A+/Stable  15-05-17  CRISIL A+/Stable  CRISIL A/Positive 
            05-07-19  CRISIL A+/Positive  09-05-18  CRISIL A+/Stable       
            01-07-19  CRISIL A+/Positive  17-04-18  CRISIL A+/Stable       
Non Fund-based Bank Facilities  LT/ST  75.00  CRISIL A1+      30-09-19  CRISIL A1  21-09-18  CRISIL A1  15-05-17  CRISIL A1  CRISIL A1 
            05-07-19  CRISIL A1  09-05-18  CRISIL A1       
            01-07-19  CRISIL A1  17-04-18  CRISIL A1       
All amounts are in Rs.Cr.
 
Annexure - Details of various bank facilities
Current facilities Previous facilities
Facility Amount (Rs.Crore) Rating Facility Amount (Rs.Crore) Rating
Cash Credit@ 150 CRISIL AA-/Stable Cash Credit@ 150 CRISIL A+/Positive
Cash Credit$ 60 CRISIL AA-/Stable Cash Credit$ 60 CRISIL A+/Positive
Cash Credit^ 80 CRISIL AA-/Stable Cash Credit^ 80 CRISIL A+/Positive
Export Packing Credit* 35 CRISIL AA-/Stable Export Packing Credit* 35 CRISIL A+/Positive
Letter of credit & Bank Guarantee 35 CRISIL A1+ Letter of credit & Bank Guarantee 35 CRISIL A1
Letter of credit & Bank Guarantee! 40 CRISIL A1+ Letter of credit & Bank Guarantee! 40 CRISIL A1
Proposed Long Term Bank Loan Facility 100 CRISIL AA-/Stable Proposed Long Term Bank Loan Facility 100 CRISIL A+/Positive
Rupee Term Loan 129 CRISIL AA-/Stable Rupee Term Loan 129 CRISIL A+/Positive
@Interchangeable between WCDL/EPC/PCFC/PSFC. Interchangeable between Overdraft/ Short Term Loan/Export & Local Bills Discounted/Export Invoice Financing
$Interchangeable between Working Capital demand loan (WCDL)/Export Packing Credit (EPC)/ Preshipment Credit in Foreign Currency (PCFC)
^Interchangeable between CC/WCDL/EPC/Foreign Usance Bills Discounting (FUBD)/Foreign Bills Purchased (FBP)/PCFC/Post Shipment Credit in Foreign Currency (PSCFC)/Inland Bills Purchased/ Discounted
*Interchangeable between Overdraft/ Short Term Loan/Export & Local Bills Discounted/Export Invoice Financing
!Interchangeable with buyer's credit
Links to related criteria
CRISILs Approach to Financial Ratios
CRISILs Bank Loan Ratings - process, scale and default recognition
Rating criteria for manufaturing and service sector companies
Rating Criteria for Chemical Industry
CRISILs Criteria for Consolidation

For further information contact:
Media Relations
Analytical Contacts
Customer Service Helpdesk
Saman Khan
Media Relations
CRISIL Limited
D: +91 22 3342 3895
B: +91 22 3342 3000
saman.khan@crisil.com

Naireen Ahmed
Media Relations
CRISIL Limited
D: +91 22 3342 1818
B: +91 22 3342 3000
naireen.ahmed@crisil.com

Anuj Sethi
Senior Director - CRISIL Ratings
CRISIL Limited
B:+91 44 6656 3100
anuj.sethi@crisil.com


Sameer Charania
Director - CRISIL Ratings
CRISIL Limited
D:+91 22 4097 8025
sameer.charania@crisil.com


Sidhaarth MS
Rating Analyst - CRISIL Ratings
CRISIL Limited
D:+91 44 6656 3138
Sidhaarth.MS@crisil.com
Timings: 10.00 am to 7.00 pm
Toll free Number:1800 267 1301

For a copy of Rationales / Rating Reports:
CRISILratingdesk@crisil.com
 
For Analytical queries:
ratingsinvestordesk@crisil.com


 

Note for Media:
This rating rationale is transmitted to you for the sole purpose of dissemination through your newspaper / magazine / agency. The rating rationale may be used by you in full or in part without changing the meaning or context thereof but with due credit to CRISIL. However, CRISIL alone has the sole right of distribution (whether directly or indirectly) of its rationales for consideration or otherwise through any media including websites, portals etc.


About CRISIL Limited

CRISIL is a leading agile and innovative, global analytics company driven by its mission of making markets function better. We are India’s foremost provider of ratings, data, research, analytics and solutions. A strong track record of growth, culture of innovation and global footprint sets us apart. We have delivered independent opinions, actionable insights, and efficient solutions to over 1,00,000 customers.
 
We are majority owned by S&P Global Inc., a leading provider of transparent and independent ratings, benchmarks, analytics and data to the capital and commodity markets worldwide.
 
For more information, visit www.crisil.com 


Connect with us: TWITTER | LINKEDIN | YOUTUBE | FACEBOOK

About CRISIL Ratings
CRISIL Ratings is part of CRISIL Limited (“CRISIL”). We pioneered the concept of credit rating in India in 1987. CRISIL is registered in India as a credit rating agency with the Securities and Exchange Board of India (“SEBI”). With a tradition of independence, analytical rigour and innovation, CRISIL sets the standards in the credit rating business. We rate the entire range of debt instruments, such as, bank loans, certificates of deposit, commercial paper, non-convertible / convertible / partially convertible bonds and debentures, perpetual bonds, bank hybrid capital instruments, asset-backed and mortgage-backed securities, partial guarantees and other structured debt instruments. We have rated over 24,500 large and mid-scale corporates and financial institutions. CRISIL has also instituted several innovations in India in the rating business, including rating municipal bonds, partially guaranteed instruments and microfinance institutions. We also pioneered a globally unique rating service for Micro, Small and Medium Enterprises (MSMEs) and significantly extended the accessibility to rating services to a wider market. Over 1,10,000 MSMEs have been rated by us.


CRISIL PRIVACY
 
CRISIL respects your privacy. We may use your contact information, such as your name, address, and email id to fulfil your request and service your account and to provide you with additional information from CRISIL.For further information on CRISIL’s privacy policy please visit www.crisil.com.


DISCLAIMER

This disclaimer forms part of and applies to each credit rating report and/or credit rating rationale that we provide (each a “Report”). For the avoidance of doubt, the term “Report” includes the information, ratings and other content forming part of the Report. The Report is intended for the jurisdiction of India only. This Report does not constitute an offer of services. Without limiting the generality of the foregoing, nothing in the Report is to be construed as CRISIL providing or intending to provide any services in jurisdictions where CRISIL does not have the necessary licenses and/or registration to carry out its business activities referred to above. Access or use of this Report does not create a client relationship between CRISIL and the user.

We are not aware that any user intends to rely on the Report or of the manner in which a user intends to use the Report. In preparing our Report we have not taken into consideration the objectives or particular needs of any particular user. It is made abundantly clear that the Report is not intended to and does not constitute an investment advice. The Report is not an offer to sell or an offer to purchase or subscribe for any investment in any securities, instruments, facilities or solicitation of any kind or otherwise enter into any deal or transaction with the entity to which the Report pertains. The Report should not be the sole or primary basis for any investment decision within the meaning of any law or regulation (including the laws and regulations applicable in the US).

Ratings from CRISIL Rating are statements of opinion as of the date they are expressed and not statements of fact or recommendations to purchase, hold, or sell any securities / instruments or to make any investment decisions. Any opinions expressed here are in good faith, are subject to change without notice, and are only current as of the stated date of their issue. CRISIL assumes no obligation to update its opinions following publication in any form or format although CRISIL may disseminate its opinions and analysis. CRISIL rating contained in the Report is not a substitute for the skill, judgment and experience of the user, its management, employees, advisors and/or clients when making investment or other business decisions. The recipients of the Report should rely on their own judgment and take their own professional advice before acting on the Report in any way.CRISIL or its associates may have other commercial transactions with the company/entity.

Neither CRISIL nor its affiliates, third party providers, as well as their directors, officers, shareholders, employees or agents (collectively, “CRISIL Parties”) guarantee the accuracy, completeness or adequacy of the Report, and no CRISIL Party shall have any liability for any errors, omissions, or interruptions therein, regardless of the cause, or for the results obtained from the use of any part of the Report. EACH CRISIL PARTY DISCLAIMS ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING, BUT NOT LIMITED TO, ANY WARRANTIES OF MERCHANTABILITY, SUITABILITY OR FITNESS FOR A PARTICULAR PURPOSE OR USE. In no event shall any CRISIL Party be liable to any party for any direct, indirect, incidental, exemplary, compensatory, punitive, special or consequential damages, costs, expenses, legal fees, or losses (including, without limitation, lost income or lost profits and opportunity costs) in connection with any use of any part of the Report even if advised of the possibility of such damages.

CRISIL Ratings may receive compensation for its ratings and certain credit-related analyses, normally from issuers or underwriters of the instruments, facilities, securities or from obligors. CRISIL’s public ratings and analysis as are required to be disclosed under the regulations of the Securities and Exchange Board of India (and other applicable regulations, if any) are made available on its web sites, www.crisil.com (free of charge). Reports with more detail and additional information may be available for subscription at a fee – more details about CRISIL ratings are available here: www.crisilratings.com.

CRISIL and its affiliates do not act as a fiduciary. While CRISIL has obtained information from sources it believes to be reliable, CRISIL does not perform an audit and undertakes no duty of due diligence or independent verification of any information it receives and / or relies in its Reports. CRISIL keeps certain activities of its business units separate from each other in order to preserve the independence and objectivity of the respective activity. As a result, certain business units of CRISIL may have information that is not available to other CRISIL business units. CRISIL has established policies and procedures to maintain the confidentiality of certain non-public information received in connection with each analytical process. CRISIL has in place a ratings code of conduct and policies for analytical firewalls and for managing conflict of interest. For details please refer to: https://www.crisil.com/en/home/our-businesses/ratings/regulatory-disclosures/highlighted-policies.html

CRISIL’s rating criteria are generally available without charge to the public on the CRISIL public web site, www.crisil.com. For latest rating information on any instrument of any company rated by CRISIL you may contact CRISIL RATING DESK at CRISILratingdesk@crisil.com, or at (0091) 1800 267 1301.

This Report should not be reproduced or redistributed to any other person or in any form without a prior written consent of CRISIL.

All rights reserved @ CRISIL